Lupin receives FDA approval for Levothyroxine Sodium Tablets

Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 m...

January 22, 2019 | Tuesday | News
J&J completes acquisition of Ci:z Holdings

Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...

January 18, 2019 | Friday | News
Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology inject...

January 18, 2019 | Friday | News
Lupin’s NaMuscla receives EC Approval

Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...

January 8, 2019 | Tuesday | News
Hetero Labs limited acquires Tarbis Farma

Telangana based Pharma company, Hetero has announced that its European subsidiary Amarox Limited has acquired Tarbis Far...

January 2, 2019 | Wednesday | News
JHL Biotech declares Phase III Study of JHL1101

JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...

December 28, 2018 | Friday | News
Dr. Reddy's lab announces the launch of Sevelamer Carbonate in US

Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...

December 28, 2018 | Friday | News
Dr. Reddy's launches Aspirin and Extended-Release Dipyridamole Capsules in USA

Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivale...

December 27, 2018 | Thursday | News
The Changing API Industry

Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...

December 17, 2018 | Monday | Opinion
Dr. Reddy’s announces the launch of Omeprazole Delayed-Release Tablets

Dr. Reddy’s has announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store...

December 11, 2018 | Tuesday | News
Amgen's Repatha shows durable treatment effect in long-term study

Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...

November 13, 2018 | Tuesday | News
FDA approves first generic version of EpiPen

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...

August 17, 2018 | Friday | News
Bayer to stop Essure sales at year-end

Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...

July 23, 2018 | Monday | News
Aurobindo to acquire Apotex's biz in European countries

Aurobindo Pharma Limited, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical...

July 16, 2018 | Monday | News
Jeil Pharma unveils new research centre

Jeil Pharmaceutical has recently opened a new technology research centre in Yongin, Gyeonggi Province. The new research...

May 16, 2018 | Wednesday | News
GB Sciences completes tech transfer of neuropathic pain formula

Singapore — GB Sciences has completed the technology transfer for the manufacturing of time-released nanoparticles...

April 4, 2018 | Wednesday | News
Propanc Biopharma Completes Reproduction run for its pancreatic drug

Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatm...

March 15, 2018 | Thursday | News
Lupin launches generic Namenda XR capsules in the US

Pharma major Lupin announced the launch of its Memantine Hydrochloride Extended-Release Capsules, 7mg, 14mg, 21mg, 28mg ...

February 21, 2018 | Wednesday | News